Fortress Biotech Inc.(FBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FBIO Fortress Biotech Inc.

盘后交易 12-16 16:44:09 EST

3.51

+0.19

+5.72%

盘后3.50

-0.01-0.28%

16:42 EST

最高3.59	最低3.21	成交量114.64万
今开3.27	昨收3.32	日振幅11.30%
总市值1.09亿	流通市值8,252万	总股本3,104万
成交额391.06万	换手率4.88%	流通股本2,351万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"FBIO","market":"US","secType":"STK","nameCN":"Fortress Biotech Inc.","latestPrice":3.51,"timestamp":1765918800000,"preClose":3.32,"halted":0,"volume":1146382,"hourTrading":{"tag":"盘后","latestPrice":3.5,"preClose":3.51,"latestTime":"16:42 EST","volume":33616,"amount":115748.8365792,"timestamp":1765921364630},"delay":0,"floatShares":23511081,"shares":31037937,"eps":-0.953861,"marketStatus":"盘后交易","change":0.19,"latestTime":"12-16 16:44:09 EST","open":3.27,"high":3.585,"low":3.21,"amount":3910639.9624834,"amplitude":0.112952,"askPrice":3.58,"askSize":2000,"bidPrice":3.35,"bidSize":1075,"shortable":3,"etf":0,"ttmEps":-0.953861,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1765933200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.32,"preHourTrading":{"tag":"盘前","latestPrice":3.28,"preClose":3.32,"latestTime":"09:28 EST","volume":8808,"amount":29171.294472,"timestamp":1765895280037},"postHourTrading":{"tag":"盘后","latestPrice":3.5,"preClose":3.51,"latestTime":"16:42 EST","volume":33616,"amount":115748.8365792,"timestamp":1765921364630},"volumeRatio":1.772317,"optionData":{"bulkOrders":[{"symbol":"FBIO","call":true,"expireDate":1768539600000,"strike":"2.5","timestamp":1765911602973,"price":1,"volume":1131,"amount":113100,"type":"-"}]},"impliedVol":2.2785,"impliedVolPercentile":0.936},"requestUrl":"/m/hq/s/FBIO/wiki","defaultTab":"wiki","newsList":[{"id":"1153698516","title":"Journey Medical Corporation公布评估Emrosi™ (Dfd-29)对健康成年人微生物群影响的临床试验结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1153698516","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153698516?lang=zh_cn&edition=full","pubTime":"2025-12-10 21:31","pubTimestamp":1765373472,"startTime":"0","endTime":"0","summary":"Journey Medical Corporation公布了评估Emrosi™ (Dfd-29)对健康成年人微生物群影响的临床试验结果，结果已刊登在《皮肤病药物杂志》上。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139","BK4007","DERM"],"gpt_icon":0},{"id":"1115885695","title":"Fortress Biotech：Cyprium将在NDA批准后保留对任何PRV的所有权，并将获得版税以及高达1.29亿美元的里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1115885695","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115885695?lang=zh_cn&edition=full","pubTime":"2025-11-17 20:37","pubTimestamp":1763383035,"startTime":"0","endTime":"0","summary":"Fortress Biotech：Cyprium将在NDA批准后保留对任何PRV的所有权，并将获得版税以及高达1.29亿美元的里程碑付款","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBIO"],"gpt_icon":0},{"id":"1126564189","title":"Fortress Biotech Inc.：在11月14日，Sentynl通知Cyprium已重新提交Cutx-101的NDA给FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=1126564189","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126564189?lang=zh_cn&edition=full","pubTime":"2025-11-17 20:33","pubTimestamp":1763382814,"startTime":"0","endTime":"0","summary":"Fortress Biotech Inc.：在11月14日，Sentynl通知Cyprium已重新提交Cutx-101的NDA给FDA","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139"],"gpt_icon":0},{"id":"1130939272","title":"Fortress Biotech及其子公司Urica Therapeutics宣布Crystalys Therapeutics全球III期Dotinurad治疗痛风临床试验首位患者接受治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1130939272","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130939272?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:31","pubTimestamp":1761049870,"startTime":"0","endTime":"0","summary":"Fortress Biotech及其子公司Urica Therapeutics宣布，Crystalys Therapeutics正在进行的全球III期Dotinurad治疗痛风的临床试验首位患者已完成用药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139"],"gpt_icon":0},{"id":"1158296044","title":"Fortress Biotech Inc.及其子公司Urica Therapeutics宣布Crystalys Therapeutics完成2.05亿美元A轮融资","url":"https://stock-news.laohu8.com/highlight/detail?id=1158296044","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158296044?lang=zh_cn&edition=full","pubTime":"2025-10-01 20:06","pubTimestamp":1759320378,"startTime":"0","endTime":"0","summary":"Fortress Biotech Inc.及其子公司Urica Therapeutics宣布Crystalys Therapeutics完成2.05亿美元A轮融资","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fortressbiotech.com","stockEarnings":[{"period":"1week","weight":0.1488},{"period":"1month","weight":0.2672},{"period":"3month","weight":-0.0321},{"period":"6month","weight":0.8343},{"period":"1year","weight":0.7113},{"period":"ytd","weight":0.6395}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fortress Biotech, Inc.于2006年6月28日在特拉华州注册成立。该公司是一家生物制药公司，专注于收购和推进资产，通过产品收入、股权持有以及股息和特许权使用费收入流为股东提升长期价值。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":0.087937},{"month":2,"riseRate":0.6,"avgChangeRate":0.010779},{"month":3,"riseRate":0.4,"avgChangeRate":-0.009436},{"month":4,"riseRate":0.4,"avgChangeRate":-0.006403},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.025034},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.018965},{"month":7,"riseRate":0.545455,"avgChangeRate":-0.008162},{"month":8,"riseRate":0.545455,"avgChangeRate":0.05815},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.057104},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.163485},{"month":11,"riseRate":0.818182,"avgChangeRate":0.114632},{"month":12,"riseRate":0.545455,"avgChangeRate":0.06548}],"exchange":"NASDAQ","name":"Fortress Biotech Inc.","nameEN":"Fortress Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fortress Biotech Inc.(FBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fortress Biotech Inc.(FBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fortress Biotech Inc.,FBIO,Fortress Biotech Inc.股票,Fortress Biotech Inc.股票老虎,Fortress Biotech Inc.股票老虎国际,Fortress Biotech Inc.行情,Fortress Biotech Inc.股票行情,Fortress Biotech Inc.股价,Fortress Biotech Inc.股市,Fortress Biotech Inc.股票价格,Fortress Biotech Inc.股票交易,Fortress Biotech Inc.股票购买,Fortress Biotech Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fortress Biotech Inc.(FBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fortress Biotech Inc.(FBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}